Healthcare Roundup: May 11, 2023 - Healthcare
Senate Health, Education, Labor, and Pensions (HELP) Committee marked up and approved several drug-pricing legislation, including the Pharmacy Benefit Manager Reform Act...
Source: mondaq.com
📰 Retaining Access News
Retaining Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Retaining Access. Real-time updates on events, politics, business and more.
Senate Once Again Tries to Address Drug Pricing | McDonnell Boehnen Hulbert & Berghoff LLP
Over the past several years Congress has tried to address high drug prices, with variable success  (see "FTC to the Rescue Regarding High Drug Prices and Patents"; "Even More...
United States John Hickenlooper Margaret Wood Hassan Michael Bennet Human Services Innovative Research Drug Pricing
Source: jdsupra.com
Washington Healthcare Update - May 2023 #2 | McGuireWoods Consulting
This Week in Washington: Debt Ceiling Continues to Loom Over the Capitol; DEA Extends COVID-19 Controlled Medications Prescribing Telehealth Flexibilities...
United States Longworth House Office Building District Of Columbia Dirksen Senate Office Building David Herman William Morris
Source: jdsupra.com
H&K Health Dose: May 2, 2023 - Healthcare
The U.S. House of Representatives is in recess while the U.S. Senate continues on with legislative business.
United States Susan Collinsr Maine Jeanne Shaheen Amy Klobachard Minn Kay Grangerr Texas Raphael Warnock
Source: mondaq.com
Executive and Legislative Healthcare Updates May 9 2023
Biden will meet House Speaker Kevin McCarthy, House Minority Leader Hakeem Jeffries, Senate Majority Leader Chuck Schumer, Senate Minority Leader Mitch McConnell at White House to discuss debt ceiling. There are few days for House and Senate to agree before June 1 default.
Source: natlawreview.com
Healthcare Preview for the Week of: May 8, 2023 | McDermott+Consulting
Debt-Limit Discussions and Ending the PHE - On Tuesday, President Biden will meet with House Speaker Kevin McCarthy, House Minority Leader Hakeem Jeffries, Senate Majority...
White House District Of Columbia United States Hakeem Jeffries Kevin Mccarthy Senate Minority Leader Mitch Mcconnell
Source: jdsupra.com
FDA Doubles Down on Its Pre-Catalyst Stance on Orphan Drug Exclusivity | Cooley LLP
On January 24, 2023, the Food and Drug Administration published a notice in the Federal Register to “address the uncertainty” created by the US Court of Appeals for the Eleventh...
United States Jacobus Pharmaceutical Co Catalyst Pharms Inc Drug Administration Us Court Office Of Orphan Products Development
Source: jdsupra.com
NORD Applauds Legislative Efforts to Restore Intent of the Orphan Drug Act
/PRNewswire/ -- The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure...
United States Peterl Saltonstall Heidi Ross National Organization For Rare Disorders Catalyst Pharms Inc Regulatory Affairs
Source: prnewswire.com
U.S. Sen. Baldwin, Colleagues: Introduce bipartisan legislation to preserve access to treatments for rare disease patients
WASHINGTON, D.C. – Today, U.S. Senators Tammy Baldwin (D-WI) and Bill Cassidy, M.D. (R-LA) introduced bipartisan legislation, the Retaining Access and Resto
United States Peterl Saltonstall Tammy Baldwin Bill Cassidy Catalyst Pharmaceuticals Inc National Organization For Rare Disorders
Source: wispolitics.com